FDA Weighs St. Jude's Promise Of Durata Production Fixes
The U.S. Food and Drug Administration said Wednesday it is reviewing St. Jude Medical Inc.'s plan to strengthen its quality control system after the agency alleged the company failed to properly...To view the full article, register now.
Already a subscriber? Click here to view full article